HEALTH
From Times Staff and Wire Reports
Pfizer to Spend $1 Billion on Drug Research: Pfizer Inc. said it will spend more than $1 billion in 1993 on research aimed at new drugs. The New York company said it already has four drugs in clinical research that have shown promising results. The four are tenidap, a prototype for a new class of drugs to treat arthritis; dofetilide, to treat heart rhythm disorders; zamifenacin, to treat irritable bowel syndrome; and CP-88,059, a new antipsychotic agent.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
